WHO ICTRP trial
Pravastatin for Hyperlipidaemia in HIV.
ACTRN12605000663651 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12605000663651 |
|---|---|
| Public title | Pravastatin for Hyperlipidaemia in HIV. |
| Scientific title | A Randomised, Double-blind Study of Pravastatin for the Treatment of Hyperlipidaemia in Patients with HIV |
| Primary sponsor | The University of New South Wales |
| Secondary sponsors | St Vincents Hospital |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | Australia |
| Conditions | HIV ;Lipid metabolism;Glucose metabolism;Metabolic abnormality;Lipodystrophy;Cardiovascular disease; HIV Lipid metabolism Glucose metabolism Metabolic abnormality Lipodystrophy Cardiovascular disease;Infection - Acquired immune deficiency… |
| Interventions | This study is a randomised, placebo-controlled study of the effect of 12 weeks treatment with the HMG-CoA reductase inhibitor, pravastatin, in HIV-infected, protease inhibitor treated patients with high serum cholesterol. We hypothesise… |
| Registration date | Oct 19, 2005 |
| Target size | 40 |
| Secondary IDs | National Heart, Lung, and Blood Institute of the National Institutes of Health: R01 HL65953-01 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: